BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25752884)

  • 1. Development and validation of the Lymphedema Symptom and Intensity Survey-Arm.
    Ridner SH; Dietrich MS
    Support Care Cancer; 2015 Oct; 23(10):3103-12. PubMed ID: 25752884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of the Lymphedema Symptom Intensity and Distress Survey-Lower Limb.
    Ridner SH; Doersam JK; Stolldorf DP; Dietrich MS
    Lymphat Res Biol; 2018 Dec; 16(6):538-546. PubMed ID: 30359205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphedema Symptom Intensity and Distress Surveys-Truncal and Head and Neck, Version 2.0.
    Ridner SH; Deng J; Doersam JK; Dietrich MS
    Lymphat Res Biol; 2021 Jun; 19(3):240-248. PubMed ID: 33181059
    [No Abstract]   [Full Text] [Related]  

  • 4. Psychometric properties of the Breast Cancer and Lymphedema Symptom Experience Index: The Chinese version.
    Shi S; Lu Q; Fu MR; Ouyang Q; Liu C; Lv J; Wang Y
    Eur J Oncol Nurs; 2016 Feb; 20():10-6. PubMed ID: 26071198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revision of the Lymphedema Functioning, Disability and Health Questionnaire for Upper Limb Lymphedema (Lymph-ICF-UL): Reliability and Validity.
    De Vrieze T; Vos L; Gebruers N; De Groef A; Dams L; Van der Gucht E; Nevelsteen I; Devoogdt N
    Lymphat Res Biol; 2019 Jun; 17(3):347-355. PubMed ID: 30759059
    [No Abstract]   [Full Text] [Related]  

  • 6. Validity and reliability of the Turkish version of the lymphedema symptom intensity and distress survey.
    Deveci Z; Karayurt Ö; Çelik B; Eyigör S
    Turk J Phys Med Rehabil; 2021 Dec; 67(4):428-438. PubMed ID: 35141483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary development of a lymphedema symptom assessment scale for patients with head and neck cancer.
    Deng J; Ridner SH; Murphy BA; Dietrich MS
    Support Care Cancer; 2012 Aug; 20(8):1911-8. PubMed ID: 22072048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Refinement and Validation of the Head and Neck Lymphedema and Fibrosis Symptom Inventory.
    Deng J; Dietrich MS; Niermann KJ; Sinard RJ; Cmelak AJ; Ridner SH; Gilbert J; Murphy BA
    Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):747-755. PubMed ID: 33068688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphedema and quality of life in Chinese women after treatment for breast cancer.
    Mak SS; Mo KF; Suen JJ; Chan SL; Ma WL; Yeo W
    Eur J Oncol Nurs; 2009 Apr; 13(2):110-5. PubMed ID: 19246241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disability, psychological distress and quality of life in breast cancer survivors with arm lymphedema.
    Pyszel A; Malyszczak K; Pyszel K; Andrzejak R; Szuba A
    Lymphology; 2006 Dec; 39(4):185-92. PubMed ID: 17319631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kwan's arm problem scale: psychometric examination in a sample of stage II breast cancer survivors.
    Nesvold IL; Fosså SD; Naume B; Dahl AA
    Breast Cancer Res Treat; 2009 Sep; 117(2):281-8. PubMed ID: 19112616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychometric evaluation of the Persian version of the Lymphedema Life Impact Scale (LLIS, version 1) in breast cancer patients.
    Haghighat S; Montazeri A; Zayeri F; Ebrahimi M; Weiss J
    Health Qual Life Outcomes; 2018 Jun; 16(1):132. PubMed ID: 29954381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body image and sexuality concerns in women with breast cancer-related lymphedema: a cross-sectional study.
    Hoyle E; Kilbreath S; Dylke E
    Support Care Cancer; 2022 May; 30(5):3917-3924. PubMed ID: 35039968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and preliminary testing of head and neck cancer related external lymphedema and fibrosis assessment criteria.
    Deng J; Ridner SH; Wells N; Dietrich MS; Murphy BA
    Eur J Oncol Nurs; 2015 Feb; 19(1):75-80. PubMed ID: 25190635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise barriers self-efficacy: development and validation of a subcale for individuals with cancer-related lymphedema.
    Buchan J; Janda M; Box R; Rogers L; Hayes S
    Health Qual Life Outcomes; 2015 Mar; 13():37. PubMed ID: 25889016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity for the simplified water displacement instrument to measure arm lymphedema as a result of breast cancer surgery.
    Sagen A; Kåresen R; Skaane P; Risberg MA
    Arch Phys Med Rehabil; 2009 May; 90(5):803-9. PubMed ID: 19406300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of life and a symptom cluster associated with breast cancer treatment-related lymphedema.
    Ridner SH
    Support Care Cancer; 2005 Nov; 13(11):904-11. PubMed ID: 15812652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast cancer survivors' experiences of lymphedema-related symptoms.
    Fu MR; Rosedale M
    J Pain Symptom Manage; 2009 Dec; 38(6):849-59. PubMed ID: 19819668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of lymphedema and arm symptoms on quality of life in breast cancer survivors.
    Hormes JM; Bryan C; Lytle LA; Gross CR; Ahmed RL; Troxel AB; Schmitz KH
    Lymphology; 2010 Mar; 43(1):1-13. PubMed ID: 20552814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity and reliability of the Swedish version of the Memorial Symptom Assessment Scale (MSAS): an instrument for the evaluation of symptom prevalence, characteristics, and distress.
    Browall M; Kenne Sarenmalm E; Nasic S; Wengström Y; Gaston-Johansson F
    J Pain Symptom Manage; 2013 Jul; 46(1):131-41. PubMed ID: 23195392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.